These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22924267)

  • 41. Cancer. A risky business--assessing breast cancer risk.
    Levy-Lahad E; Plon SE
    Science; 2003 Oct; 302(5645):574-5. PubMed ID: 14576407
    [No Abstract]   [Full Text] [Related]  

  • 42. Is BRCA1/BRCA2-related breast carcinogenesis estrogen dependent?
    Noruzinia M; Coupier I; Pujol P
    Cancer; 2005 Oct; 104(8):1567-74. PubMed ID: 16155942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can genetic testing guide treatment in breast cancer?
    Tutt A; Ashworth A
    Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experts say more women should be tested for BRCA1 and BRCA2 genetic mutations.
    Printz C
    Cancer; 2020 Feb; 126(4):693. PubMed ID: 31995244
    [No Abstract]   [Full Text] [Related]  

  • 45. BRCA1, BRCA2 and breast cancer: a concise clinical review.
    Carter RF
    Clin Invest Med; 2001 Jun; 24(3):147-57. PubMed ID: 11437066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In familial breast or ovarian carcinoma: normal cancer prevention is not enough].
    Riem L
    MMW Fortschr Med; 2004 Apr; 146(15):12. PubMed ID: 15373015
    [No Abstract]   [Full Text] [Related]  

  • 48. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2.
    Scalia-Wilbur J; Colins BL; Penson RT; Dizon DS
    Semin Radiat Oncol; 2016 Jan; 26(1):3-8. PubMed ID: 26617204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical significance of recognizing distinct morphologic and biologic features of hereditary breast cancer.
    Masood S
    Breast J; 2002; 8(2):69. PubMed ID: 11896749
    [No Abstract]   [Full Text] [Related]  

  • 51. Screening for Genetic Testing in Breast Cancer - Are We Missing the Full Picture?
    McCormick G; Mikropoulos C; Sadler G; Abson C; Davis A; Hall J
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):226. PubMed ID: 26254840
    [No Abstract]   [Full Text] [Related]  

  • 52. Myriad Genetics embroiled in breast-cancer data fight - again.
    Check Hayden E
    Nature; 2016 May; 533(7604):449. PubMed ID: 27225096
    [No Abstract]   [Full Text] [Related]  

  • 53. Risk assessment for hereditary breast cancer: BRCA1 and BRCA2.
    Seenandan-Sookdeo KA; Sawatzky JA
    Can Oncol Nurs J; 2010; 20(3):107-15. PubMed ID: 20812602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
    Bonadona V; Sinilnikova OM; Lenoir GM; Lasset C
    J Natl Cancer Inst; 2002 Oct; 94(20):1582-3; author reply 1583-4. PubMed ID: 12381714
    [No Abstract]   [Full Text] [Related]  

  • 55. Breast cancer risk assessment and genetic testing: complexities, conundrums, and community.
    Peshkin BN
    Breast Dis; 2006-2007; 27():1-3. PubMed ID: 17917137
    [No Abstract]   [Full Text] [Related]  

  • 56. Modeling genetic risk of breast cancer.
    Kauff ND; Offit K
    JAMA; 2007 Jun; 297(23):2637-9. PubMed ID: 17579233
    [No Abstract]   [Full Text] [Related]  

  • 57. Limited family structure and breast cancer risk.
    Iversen ES; Katki HA; Chen S; Berry DA; Parmigiani G
    JAMA; 2007 Nov; 298(17):2007; author reply 2007-8. PubMed ID: 17986693
    [No Abstract]   [Full Text] [Related]  

  • 58. JAMA patient page. Genetics and breast cancer.
    Parmet S; Lynm C; Glass RM
    JAMA; 2004 Jul; 292(4):522. PubMed ID: 15280351
    [No Abstract]   [Full Text] [Related]  

  • 59. Patient information. Should I be tested for the BRCA gene?
    Gore J
    JAAPA; 2009 Sep; 22(9):57-8. PubMed ID: 19827400
    [No Abstract]   [Full Text] [Related]  

  • 60. Curating the way to better determinants of genetic risk.
    Phimister EG
    N Engl J Med; 2015 Jun; 372(23):2227-8. PubMed ID: 26014597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.